David Shaw’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-40,000
Closed -$268K 4472
2023
Q4
$268K Hold
40,000
﹤0.01% 3783
2023
Q3
$225K Hold
40,000
﹤0.01% 3726
2023
Q2
$221K Hold
40,000
﹤0.01% 3712
2023
Q1
$250K Hold
40,000
﹤0.01% 3815
2022
Q4
$186K Hold
40,000
﹤0.01% 4264
2022
Q3
$187K Hold
40,000
﹤0.01% 4489
2022
Q2
$237K Hold
40,000
﹤0.01% 4470
2022
Q1
$773K Sell
40,000
-20,000
-33% -$459K ﹤0.01% 4107
2021
Q4
$1.96M Sell
60,000
-30,000
-33% -$1.21M ﹤0.01% 3378
2021
Q3
$3.69M Buy
90,000
+50,000
+125% +$1.81M ﹤0.01% 2413
2021
Q2
$1.44M Buy
+40,000
New +$1.48M ﹤0.01% 3254

Other funds holding GDRX

David Shaw's GDRX Position: Q2 2026 in Review

David Shaw increased its GoodRx Holdings (GDRX) stake by 53% in Q2 2026, buying an estimated $421K and bringing the position to 477,703 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #3514.

David Shaw first reported a position in GDRX in Q2 2021 and has held it in 18 quarters since. The position peaked at $8.32M in Q1 2023. 160 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • David Shaw held 477,703 shares of GoodRx Holdings worth $1.38M as of Q2 2026.
  • David Shaw bought 165,575 GoodRx Holdings shares in Q2 2026, an estimated $421K.
  • GoodRx Holdings made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3514 holding.
  • David Shaw first reported a position in GoodRx Holdings in Q2 2021 and has held it in 18 quarters since.
  • David Shaw's GoodRx Holdings position peaked at $8.32M in Q1 2023.
  • 160 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.